Publisher
Springer International Publishing
Reference240 articles.
1. Abedin MR, Powers K, Aiardo R, Barua D, Barua S (2021) Antibody-drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells. Sci Rep 11(1):7347. https://doi.org/10.1038/s41598-021-86762-6
2. Abouzeid AH, Patel NR, Rachman IM, Senn S, Torchilin VP (2013) Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin. J Drug Target 21(10):994–1000. https://doi.org/10.3109/1061186x.2013.840639
3. Adams GP, Schier R, McCall AM, Simmons HH, Horak EM, Alpaugh RK, Marks JD, Weiner LM (2001) High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res 61(12):4750–4755
4. Aggarwal S, Yadav S, Gupta S (2011) EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer. J Biomed Nanotechnol 7(1):137–138. https://doi.org/10.1166/jbn.2011.1238
5. Aggarwal S, Gupta S, Pabla D, Murthy RS (2013) Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer. Cancer Nanotechnol 4(6):145–157. https://doi.org/10.1007/s12645-013-0046-3